Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Neuroendocrine Tumors in Lung × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 106 Gastro-enteropancreatic neuroendocrine tumor 19 Neoplasms 16 Carcinoid Tumor 15 Colorectal Neoplasms 12 Carcinoma 10 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Neuroendocrine 7 Carcinoma, Hepatocellular 7 Serotonin Syndrome 6 Sarcoma 6 Prostatic Neoplasms 6 Pancreatic Neoplasms 6 Digestive System Neoplasms 6 Carcinoma, Renal Cell 6 Breast Neoplasms 6 Adenoma, Islet Cell 6 Stomach Neoplasms 5 Small Cell Lung Carcinoma 5 Pheochromocytoma 5 Paraganglioma 5 Melanoma 5 Lung Neoplasms 5 Head and Neck Neoplasms 5 Gastroenteropancreatic Neuroendocrine Tumors 5 Cholangiocarcinoma 5 Thyroid Neoplasms 4 Ovarian Neoplasms 4 Neuroectodermal Tumors, Primitive 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02683941 2022-07-06

SPINET

Ipsen

Phase 3 Terminated

77 enrolled 20 charts

Neuroendocrine Tumors in Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡